These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 106558)

  • 1. [Modern trends in vaccination policy: evaluation of benefits, risks and cost (author's transl)].
    Wiedermann G
    Wien Klin Wochenschr; 1979 Mar; 91(5):143-50. PubMed ID: 106558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in the benefit of immunization].
    Ambrosch VF; Wiedermann G; Kundi M
    Fortschr Med; 1977 Jan; 95(3):159-62. PubMed ID: 838425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of risk and benefit in immunization against pertussis and tuberculosis.
    Ambrosch F; Wiedermann G
    Dev Biol Stand; 1979; 43():85-90. PubMed ID: 520688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Trendobservation of beneficial effects of vaccinations (author's transl)].
    Ambrosch F; Wiedermann G; Kundi M
    Zentralbl Bakteriol Orig A; 1977 Dec; 239(4):541-7. PubMed ID: 610249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-benefit calculations of vaccinations against measles and mumps in Austria.
    Wiedermann G; Ambrosch F
    Dev Biol Stand; 1979; 43():273-7. PubMed ID: 118067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccination status of children in the Vienna area (author's transl)].
    Kessler T
    Wien Klin Wochenschr; 1978 Dec; 90(23):835-8. PubMed ID: 741751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Costs and benefits of measles vaccination].
    Ambrosch F; Wiedermann G; Harasek G
    Fortschr Med; 1978 Feb; 96(8):409-14. PubMed ID: 415953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-benefit analysis of BCG-vaccination in Austria.
    Ambrosch F; Klima H; Wiedermann G
    Dev Biol Stand; 1979; 43():121-6. PubMed ID: 118066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for risk-benefit and cost-benefit analysis of vaccinations.
    Wiedermann G; Ambrosch F
    Dev Biol Stand; 1979; 43():429-32. PubMed ID: 118070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vaccination in childhood. Indications towards change].
    Stephan U
    Fortschr Med; 1977 Feb; 95(5):253-5. PubMed ID: 838443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect, hazards and risks of the new vaccination against tick-borne encephalitis (TBE) as calculated by special formulas (author's transl)].
    Wiedermann G; Kunz C; Ambrosch F
    Zentralbl Bakteriol Orig A; 1976 Nov; 236(2-3):141-4. PubMed ID: 1015006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The contribution of social medicine to vaccination in Austria].
    Kunze M
    Wien Med Wochenschr; 1998; 148(8-9):191-7. PubMed ID: 9677675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.
    Zhou F; Reef S; Massoudi M; Papania MJ; Yusuf HR; Bardenheier B; Zimmerman L; McCauley MM
    J Infect Dis; 2004 May; 189 Suppl 1():S131-45. PubMed ID: 15106102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks and benefits of vaccinations.
    Wiedermann G; Ambrosch F; Kollaritsch H; Kundi M
    Infect Control; 1984 Sep; 5(9):438-44. PubMed ID: 6567619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vaccination: I. What has proved useful? (author's transl)].
    Spiess H
    MMW Munch Med Wochenschr; 1979 Apr; 121(14):489-92 contd. PubMed ID: 107439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs and benefits of measles and mumps immunization in Austria.
    Wiedermann G; Ambrosch F
    Bull World Health Organ; 1979; 57(4):625-9. PubMed ID: 118811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mathematical methods to judge the efficiency of protective vaccinations (author's transl)].
    Ambrosch F; Wiedermann G
    Immun Infekt; 1975 Feb; 3(1):24-31. PubMed ID: 1184094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current problems of vaccination, especially in France (author's transl)].
    Letonturier P
    MMW Munch Med Wochenschr; 1975 Aug; 117(31):1289-94. PubMed ID: 819786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.